Preparation and preclinical assessment of folate-conjugated, radiolabelled antibodies

Anticancer Research

Volumn 25, Issue 1 A, 2005, Pages 9-15

  Henriksen, Gjermund ^a   Bruland, Øyvind S ^b   Larsen, Roy H ^c  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c Algeta ASA   (Norway)

Author keywords

Alpha particle emitter; Folate conjugate; Folate receptor; Targeted radiotherapy

Indexed keywords

ANTIGEN; ASTATINE 211; FOLATE BINDING PROTEIN; FOLATE RECEPTOR; FOLIC ACID; GAMMANORM; HUMAN IMMUNOGLOBULIN; HUMAN IMMUNOGLOBULIN 6; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IODINE 125; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY TP1; MONOCLONAL ANTIBODY TP3; RADIOISOTOPE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; DRUG CONJUGATION; DRUG PROTEIN BINDING; DRUG TARGETING; EVALUATION; FEMALE; HELA CELL; HUMAN; HUMAN CELL; ISOTOPE LABELING; KIDNEY CLEARANCE; MOUSE; MOUSE STRAIN; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; ASTATINE; CARRIER PROTEINS; FEMALE; FOLIC ACID; HELA CELLS; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN G; IODINE RADIOISOTOPES; KINETICS; MICE; MICE, INBRED BALB C; OSTEOSARCOMA; RADIOPHARMACEUTICALS; RECEPTORS, CELL SURFACE; TISSUE DISTRIBUTION; TRITIUM;

EID: 16444384824     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kamen BA, Wang MT, Streckfuss AJ, Peryea X and Anderson RGW: Delivery of folates to the cyctoplasm of MA104 cells is mediated by a surface membrane receptor that recyles. J Biol Chem 263: 13602-13609, 1988.
2. Campbell IG, Jones TA, Foulkes WD and Trowsdale J: Folate binding protein is a marker for ovarian cancer. Cancer Res 57: 5329-5338, 1991.
3. Coney LR, Tomassetti A, Carayannopoulos L, Frasca V, Kamen BA, Colnaghi MI and Zurawski VR Jr: Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate binding protein. Cancer Res 57: 6125-6132, 1991.
4. Mattes MJ, Major PP, Goldenberg DM, Dion AS, Hutter RVP and Klein KM: Patterns of antigen distribution in human carcinomas. Cancer Res (suppl) 50: S880-S884, 1990.
5. Weitman SD, Lark RH, Coney LR, Fort DW, Frasca V, Zurawski VR and Kamen BA: Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res 52: 3396-3401, 1992.
6. Reddy JA and Low PS: Folate-mediated targeting of therapeutic and imaging agents to cancers. Crit Rev Therap Drug Carrier Syst 75: 587-627, 1998.
7. Wang S and Low PS: Folate mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells. J Control Release 53: 39-48, 1998.
8. Morshed KM, Ross DM and McMartin KE: Folate transport proteins mediate the bidirectional transport of 5-methyltetrahydrofolate in cultured human proximal tubule cells. J Nutr 727: 1137-1147, 1997.
9. Mathias CJ, Wang S, Lee RJ, Waters DJ, Low PS and Green MA: Tumor selective radiopharmaceutical targeting via receptor-mediated endocytosis of Gallium-67 deferoxamine-folate. J Nucl Med 37: 1003-1008, 1996.
10. Mathias CJ, Wang S, Waters DJ, Turek JJ, Low PS and Green MA: Indium-111-DTPA-Folate as a potential folate receptor targeted radiopharmaceutical. J Nucl Med 39: 1579-1585, 1998.
11. Bruland ØS: Cancer therapy with radiolabeled antibodies. An overview. Acta Oncol 34: 1085-1094, 1995.
12. Abrahams PG and Fritzberg A (Eds): Radioimmunotherapy of Cancer. Marcel Dekker, Inc., New York, 2000.
13. 111In]DTPA-Folate for use as a tumor targeted radiopharmaceutical. Bioconj Chem 8: 673-679, 1997.
14. 211At in a murine intraperitoneal tumor model. Gynecol Oncol 57: 9-15, 1995.
15. Leamon CP and Low PS: Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Proc Natl Acad Sci USA 88: 5572-5576, 1991.
16. Kranz DM, Patrick TA, Brigle KE, Spinella MJ and Roy EJ: Conjugates of folate and anti-T-receptor antibodies specifically target folate-receptor tumor cells for lysis. Proc Natl Acad Sci USA 92: 9057-9061, 1995.
17. Bruland ØS, Fodstad Ø, Funderud S and Phil A: New monoclonal antibodies specific for human sarcomas. Int J Cancer 38: 27-31, 1986.
18. Bruland ØS, Fodstad Ø, Stenwig AE and Phil A: Expression and characteristics of a novel human osteosarcoma-associated cell surface antigen. Cancer Res 48: 5302-5309, 1988.
19. 125I-labelled monoclonal antibodies. Biodistribution in mice carrying human osteosarcoma xenografts. J Labelled Compds Radiopharm 34: 773-785, 1994.
20. Fraker PJ and Speck JC Jr: Protein and cell membrane iodination with a sparingly soluble chloramine. 1,3,4, 6-tetrachloro-3a, 6a-diphenyl glucouril. Biochem Biophys Res Comm 80: 849-855, 1978.
21. Garg PK, Archer GE, Bigner DD and Zalutsky MR: Synthesis of radioiodinated N-succinimidyl iodobenzoate: optimization for use in antibody labelling. Appl Radiat Isot 40: 485-490, 1989.
22. Fodstad Ø, Brøgger A, Bruland ØS, Solheim ØP, Nesland JM and Pihl A: Characteristics of a cell line established from a patient with multiple ostesarcoma appearing 13 years after treatment for bilateral retinoblastoma. Int J Cancer 38: 33-40, 1988.
23. 211At-TP-3 monoclonal antibody: comparison with astatine-211 labeled bovine serum albumine, free astatine-211 and external beam x-rays. Radiat Res 139: 178-184, 1994.
24. Royal Society/Universities Federation for Animal Welfare (UFAW). Guidelines on the Care of Laboratory Animals and Their Use for Scientific Purposes, part 1- Housing and Care. UFAW. 1987.
25. Meredith RF, Khazaeli MB, Plott WE, Liu T, Russel CD, Wheeler RH and Lobuglio AF: Effect on human immune-response on repeat courses of I-131 chimeric B72.3 antibody therapy. Antibody Immunoconj Radiopharm 6: 39-46, 1993.